Davis Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Davis Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.45K	Hold	22	–	–	﹤0.01%	310
2026 Q1	$4.42K	Hold	22	–	–	﹤0.01%	261
2025 Q4	$4.54K	Hold	22	–	–	﹤0.01%	267
2025 Q3	$3.94K	Buy	+22	New	+$3.75K	﹤0.01%	277
2025 Q1	$3.74K	Hold	22	–	–	﹤0.01%	272
2024 Q4	$3.66K	Hold	22	–	–	﹤0.01%	271
2024 Q3	$3.78K	Hold	22	–	–	﹤0.01%	286
2024 Q2	$3.38K	Buy	+22	New	+$3.3K	﹤0.01%	280

Other funds holding FBT

JWS

Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

OPAM

Ocean Park Asset Management Santa Monica, California $2.08B AUM 5.32% 1-Year Est. Return

QCIG

Quad-Cities Investment Group Davenport, Iowa $278M AUM 22.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

FEG

Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return

TCOO

Trust Company of Oklahoma Tulsa, Oklahoma $389M AUM 34.72% 1-Year Est. Return

Stablepoint Partners Braintree, Massachusetts $723M AUM 29.31% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

IWM

Iams Wealth Management Omaha, Nebraska $332M AUM 18.77% 1-Year Est. Return

Davis Capital Management's FBT Position: Q2 2026 in Review

Davis Capital Management held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q2 2026 at 22 shares worth $5.45K. The position accounts for ﹤0.01% of the portfolio, ranked #310.

Davis Capital Management first reported a position in FBT in Q2 2024 and has held it in 8 quarters since. 51 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

Davis Capital Management held 22 shares of First Trust NYSE Arca Biotechnology Index Fund worth $5.45K as of Q2 2026.
Davis Capital Management left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Davis Capital Management's portfolio in Q2 2026, its #310 holding.
Davis Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2024 and has held it in 8 quarters since.
51 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.